FI905189A0 - Kvalitativ och kvantitativ bestaemning av rasproteiner i kroppsvaetskor och -vaevnader samt klassificering av dessa. - Google Patents

Kvalitativ och kvantitativ bestaemning av rasproteiner i kroppsvaetskor och -vaevnader samt klassificering av dessa.

Info

Publication number
FI905189A0
FI905189A0 FI905189A FI905189A FI905189A0 FI 905189 A0 FI905189 A0 FI 905189A0 FI 905189 A FI905189 A FI 905189A FI 905189 A FI905189 A FI 905189A FI 905189 A0 FI905189 A0 FI 905189A0
Authority
FI
Finland
Prior art keywords
conditioning
rasproteiners
klassificering
dessa
samt
Prior art date
Application number
FI905189A
Other languages
English (en)
Finnish (fi)
Inventor
Walter Patrick Carney
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of FI905189A0 publication Critical patent/FI905189A0/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
FI905189A 1988-04-22 1990-10-22 Kvalitativ och kvantitativ bestaemning av rasproteiner i kroppsvaetskor och -vaevnader samt klassificering av dessa. FI905189A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18558288A 1988-04-22 1988-04-22
US33482389A 1989-04-11 1989-04-11
PCT/US1989/001615 WO1989010565A1 (fr) 1988-04-22 1989-04-20 Detection, quantification et classification de proteines ras dans des fluides et des tissus corporels

Publications (1)

Publication Number Publication Date
FI905189A0 true FI905189A0 (fi) 1990-10-22

Family

ID=26881267

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905189A FI905189A0 (fi) 1988-04-22 1990-10-22 Kvalitativ och kvantitativ bestaemning av rasproteiner i kroppsvaetskor och -vaevnader samt klassificering av dessa.

Country Status (9)

Country Link
EP (2) EP0411018B1 (fr)
JP (1) JPH0816679B2 (fr)
AT (2) ATE258686T1 (fr)
AU (1) AU634961B2 (fr)
CA (1) CA1340368C (fr)
DE (2) DE68928106T2 (fr)
DK (1) DK254390A (fr)
FI (1) FI905189A0 (fr)
WO (1) WO1989010565A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028527A (en) * 1988-02-22 1991-07-02 Applied Bio Technology Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
GB9103974D0 (en) * 1991-02-26 1991-04-10 Norsk Hydro As Therapeutically useful peptides or peptide fragments
US6087188A (en) * 1992-11-13 2000-07-11 Alk A/S Two-site immunoassay for an antibody with chemiluminescent label and biotin bound ligand
AU5587998A (en) * 1996-11-15 1998-06-03 Cornell Research Foundation Inc. Activated ras interaction assay
JP4693902B2 (ja) * 2005-06-23 2011-06-01 バイエル ヘルスケア エルエルシー 体液中のｒａｓｐ２１の定量的検定法
US9186405B2 (en) 2007-08-16 2015-11-17 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
US20100255514A1 (en) 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228237A (en) * 1978-09-21 1980-10-14 Calbiochem-Behring Corp. Methods for the detection and determination of ligands
JPS5837713B2 (ja) 1978-12-01 1983-08-18 富士通株式会社 半導体レ−ザ−装置の製造方法
SE447028B (sv) * 1980-06-30 1986-10-20 Erik Audunn Cerven Bestemning av endstaende sackaridgrupper i glykoprotein
US4535058A (en) * 1982-10-01 1985-08-13 Massachusetts Institute Of Technology Characterization of oncogenes and assays based thereon
US4504585A (en) * 1982-04-05 1985-03-12 Aalto Scientific, Ltd. Affinity immunoassay system
US4699877A (en) 1982-11-04 1987-10-13 The Regents Of The University Of California Methods and compositions for detecting human tumors
CA1219232A (fr) 1983-08-17 1987-03-17 Richard A. Lerner Recepteurs monoclonaux induits par un polypeptide contre des ligands
US4725550A (en) * 1984-01-19 1988-02-16 Research Foundation Of State University Of New York Novel mutation of the c-K-ras oncogene activated in a human lung carcinoma
US4762706A (en) * 1984-10-17 1988-08-09 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
US4798787A (en) * 1984-09-19 1989-01-17 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
JPS6185327A (ja) * 1984-09-19 1986-04-30 シタス　コーポレイシヨン 発癌遺伝子生成物に対する抗体
GB8501563D0 (en) * 1985-01-22 1985-02-20 Kodak Ltd Uv-absorbing polymers
CA1296660C (fr) * 1985-01-29 1992-03-03 Walter P. Carney Anticorps monoclonal dirige contre un dodecapeptide relie a un oncogene p21 ras
US5028527A (en) * 1988-02-22 1991-07-02 Applied Bio Technology Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
AU3533089A (en) * 1988-04-22 1989-11-24 E.I. Du Pont De Nemours And Company Monoclonal antibodies specific for the harvey, kirsten, and n ras proteins and their use as diagnostic reagents
TWI228804B (en) 2003-07-02 2005-03-01 Lite On Semiconductor Corp Chip package substrate having flexible printed circuit board and method for fabricating the same

Also Published As

Publication number Publication date
DK254390A (da) 1990-12-21
DE68929511T2 (de) 2004-11-18
WO1989010565A1 (fr) 1989-11-02
EP0767381B1 (fr) 2004-01-28
ATE154134T1 (de) 1997-06-15
DE68928106T2 (de) 1997-12-04
DE68929511D1 (de) 2004-03-04
DK254390D0 (da) 1990-10-22
EP0767381A1 (fr) 1997-04-09
JPH03505250A (ja) 1991-11-14
DE68928106D1 (de) 1997-07-10
AU3447989A (en) 1989-11-24
AU634961B2 (en) 1993-03-11
JPH0816679B2 (ja) 1996-02-21
EP0411018A1 (fr) 1991-02-06
EP0411018B1 (fr) 1997-06-04
ATE258686T1 (de) 2004-02-15
EP0411018A4 (en) 1991-08-21
CA1340368C (fr) 1999-02-02

Similar Documents

Publication Publication Date Title
CY1115366T1 (el) Δεικτες ογκου
DK0991421T3 (da) Påvisning og modulering af IAP'er og NAIP i forbindelse med diagnose og behandling af proliferativ sygdom
DE69033067D1 (de) 4,7-dichlorfluoreszein-farbstoffe als molekulare sonden
EP1099102A4 (fr) Utilisation d'une olfactometrie artificielle pour detecter le niveau de presence de substances a analyser
WO1995016919A3 (fr) Procedes et compositions s'appliquant a la detection de cancers du colon
GR1000751B (el) Ανιχνευτης νουκλεινικου οξεος δια την ανιχνευσιν του neisseria gonorrhoea.
Adrover et al. Expression of high p53 levels in colorectal cancer: a favourable prognostic factor
KR890015714A (ko) 폐암의 조기 검출 방법
FI905189A0 (fi) Kvalitativ och kvantitativ bestaemning av rasproteiner i kroppsvaetskor och -vaevnader samt klassificering av dessa.
ES2116331T3 (es) Deteccion del contenido en sindecan en los materiales biologicos tales como tejidos o fluidos fisiologicos que indican transformaciones celulares malignas.
DE3850249D1 (de) Nachweis von analyt in partikel enthaltenden proben.
KR950704509A (ko) 감염증 진단용 프로브
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
FI922666A0 (fi) Diagnostiskt foerfarande.
ATE323176T1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
Horn et al. An improved fluorochrome microassay for the detection of living and non-living intracellular bacteria in human neutrophils
FI990380A0 (fi) Diagnostinen ja seulontamenetelmä
Höffken et al. Quantitation of immune complexes by nephelometry
Petsche et al. A flow cytometric method for the detection of adenosine deaminase in mononuclear cells
Saunders et al. 2D-gel analysis of protein synthesis profiles of different stages of chronic lymphocytic leukaemia
Burton et al. Tissue antigens in ovarian carcinoma
Wilson Immunological Tests m the Diagnosis of Cancer
SCHNITT Case selection does not permit conclusions.
Pellegrini et al. Two bioassays for the evaluation of the toxicity of sediments in the Port of Piombino

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: E.I. DU PONT DE NEMOURS AND COMPANY